- AdventHealth Research Institute
AdventHealth was recently featured in Becker's Healthcare's 2024 list of 100+ hospitals and health systems with great oncology programs. Citing our 175 clinical trials annually and roughly 50 cancer-dedicated research employees as key factor to our inclusion. You can read more about this in their article by clicking the button below.
Recent News
AdventHealth Research Institute and NESTRE Health & Performance Announce Collaboration to Advance Neurocognitive Health and Performance Through Cognitive Training
“We are at a pivotal point in our understanding of neuroscience and in particular, neuroplasticity – the ability of neural networks in the brain to change through growth and reorganization. This new...
Anita Fletcher, MD | Appointed by NKGen as National Principal Investigator for Phase 2a Troculeucel Trial
NKGen Biotech today announced that Anita Fletcher, M.D. has been appointed as the National Principal Investigator (“PI”) for its Phase 2a clinical trial of troculeucel.
AdventHealth Research Contributed to New Method for Tracking Diet and Its Impacts on Human Health
Accurately determining food intake remains a challenge in nutrition research. A new study published in Nature Metabolism, introduces a metagenomics-powered approach to accurately track dietary intake...
Accelerating Orthopedic Innovation Through Research
In this blog Dr. Amir Kachooei shares his view on AdventHealth's orthopedic research efforts and the future of orthopedic medicine.
Dr. Wassim McHayleh Breast Cancer Research Patient Story - Florida Trend
Dr. Wassim McHayleh featured in article about breast cancer research.
Wassim McHayleh, MD | An Investigational Breast Cancer Drug Has Been a Game Changer for a Central FL Patient
Florida Trend for Breast Cancer Month features Dr. McHayleh and his clinical trial Tropion! A participant in the study was declared cancer-free after about 5 months of treatment.